Recent developments in tuberculosis vaccines

  • Marinova D
  • Gonzalo-Asensio J
  • Aguilo N
 et al. 
  • 75


    Mendeley users who have this article in their library.
  • 20


    Citations of this article.


Substantial efforts have been made over the past decade to develop vaccines against tuberculosis. We review recent developments in tuberculosis vaccines in the global portfolio, including those designed for use in a prophylactic setting, either alone or as boosts to Bacille Calmette–Gué rin, and therapeutic vaccines designed to improve chemotherapy. While there is no doubt that progress is still being made, there are limitations to our animal model screening processes, which are further amplified by the lack of understanding of the immunological responses involved and the precise type of long-lived immunity that new vaccines need to induce. The challenge ahead is to optimize the planning for advanced clinical trials in poor endemic settings, which could be greatly facilitated by identifying correlates of protection.

Author-supplied keywords

  • BCG-replacement strategies
  • animal models
  • clinical development
  • mucosal delivery route
  • regulatory aspects
  • tuberculosis vaccines

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text


  • Dessislava Marinova

  • Jesus Gonzalo-Asensio

  • Nacho Aguilo

  • Carlos Martin

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free